5517 Results

People

  1. O'Reilly
    O'Reilly
  2. Scheinberg
    Scheinberg
  3. Levine
    Levine
  4. Cheung
    Cheung
  5. Hricak
    Hricak
  6. Massague
    Massague
  7. Lewis
    Lewis
  8. Kernan
    Kernan
  9. Rudin
    Rudin
  10. Rajadhyaksha
    Rajadhyaksha

Groups

  1. Center for Molecular Imaging and Biotechnology (5517)
  2. GSK Faculty (5319)
  3. Sloan Kettering Institute Faculty (3448)
  4. Tow Center for Developmental Oncology (TCDO) (2542)
  5. Department of Medicine (2440)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1825)
  7. Center for Hematologic Malignancies (1694)
  8. Sloan Kettering Institute Postdocs (1657)
  9. Hematologic Malignancies, Division of (1367)
  10. Molecular Pharmacology and Chemistry Program Faculty (1341)
  1. "Center for Molecular Imaging and Biotechnology"
Formats
  1. Journal Article (3380)
  2. Meeting Abstract (1548)
  3. Review (164)
  4. Conference Paper (128)
  5. Book Section (124)
  6. Editorial (107)
  7. Research Letter (27)
  8. Miscellaneous (14)
  9. Book Whole (11)
  10. Guidelines (9)
  11. Correspondence (5)
Groups
  1. Center for Molecular Imaging and Biotechnology (5517)
  2. GSK Faculty (5319)
  3. Sloan Kettering Institute Faculty (3448)
  4. Tow Center for Developmental Oncology (TCDO) (2542)
  5. Department of Medicine (2440)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1825)

More Groups

People
  1. Richard O'Reilly (662)
  2. David Scheinberg (445)
  3. Ross Levine (432)
  4. Nai-Kong Cheung (419)
  5. Hedvig Hricak (387)
  6. Joan Massague (351)

More People

Years
  1. 2025 (1)
  2. 2024 (150)
  3. 2023 (248)
  4. 2022 (308)
  5. 2021 (289)
  6. 2020 (331)

More Years

Publications
  1. Blood (632)
  2. Cancer Research (190)
  3. Journal of Clinical Oncology (170)
  4. Journal of Nuclear Medicine (139)
  5. Biology of Blood and Marrow Transplantation (101)
  6. Proceedings of the National Academy of Sciences of the United States of America (95)

More Publications

Publishers
  1. American Society of Hematology (662)
  2. Nature Publishing Group (527)
  3. Elsevier Inc. (454)
  4. American Association for Cancer Research (369)
  5. Cell Press (355)
  6. Springer (202)

More Publishers

Results (5517)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combined JAK2 and ERK1/2 kinase inhibition as a novel therapeutic approach in myeloproliferative neoplasms
    Meeting Abstract

    Brkic, S.; Stivala, S.; Santopolo, A.; Jungius, S.; Passweg, J. R.; Tsakiris, D.; Dirnhofer, S.; Levine, R. L.; Meyer, S. C.
    Oncology Research and Treatment (2020)

    Fulltext@MSK | Save
  • Resistance to type II JAK2 inhibition in MPN is dependent on MEK-ERK activation and is targetable
    Meeting Abstract

    Codilupi, T.; Szybinski, J.; Wicki, A.; Yang, J. L.; Ghosh, N.; Passweg, J.; Tsakiris, D.; Levine, R. L.; Koche, R.; Meyer, S. C.
    Oncology Research and Treatment (2020)

    Fulltext@MSK | Save
  • Dual genetic targeting of ERK1 and ERK2 abrogates the competitive potential of the myeloproliferative neoplasm clone
    Meeting Abstract

    Stivala, S.; Brkic, S.; Santopolo, A.; Dirnhofer, S.; Passweg, J.; Tsakiris, D.; Neel, B.; Levine, R.; Meyer, S.
    Oncology Research and Treatment (2020)

    Fulltext@MSK | Save
  • Self-Assembling and DisAssembling bispecific antibodies for curative 2-step pretargeted radioimmunotherapy
    Meeting Abstract

    Santich, B.; Cheal, S.; Ahmed, M.; McDevitt, M.; Ouerfelli, O.; Veach, D.; Fung, E.; Burnes Vargas, D.; Malik, A.; Guo, H. F.; more...
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Multicycle pretargeted radioimmunotherapy using 177(Lu) for intraperitoneal GPA33-expressing colorectal xenografts
    Meeting Abstract

    Chandler, C.; Cheal, S.; Nash, G.; Cercek, A.; Punzalan, B.; Veach, D.; Xu, H.; Guo, H. F.; Larson, S.; Cheung, N. K.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Pretargeted radioimmunotherapy using 225(Ac) for intraperitoneal GPA33-expressing colorectal xenografts
    Meeting Abstract

    Chandler, C.; Cheal, S.; Nash, G.; Cercek, A.; McDevitt, M.; Xu, H.; Guo, H. F.; Cheung, N. K.; Larson, S.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Pretargeted alpha radioimmunotherapy (DOTA-PRIT) for HER2-expressing human gastric cancer: A theranostic approach using 111(In)/225(Ac)-radiohapten
    Meeting Abstract

    Cheal, S.; McDevitt, M.; Burnes Vargas, D.; Veach, D.; Punzalan, B.; Xu, H.; Guo, H. F.; Ouerfelli, O.; Cheung, N. K.; Larson, S.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • (225)Ac-alpha pretargeted radioimmunotherapy (DOTA-PRIT) of human colorectal cancer: Achieving 100% complete responses with single-cycle targeting of 2 distinct antigens, HER2 and GPA33
    Meeting Abstract

    Cheal, S.; McDevitt, M.; Burnes Vargas, D.; Veach, D.; Punzalan, B.; Xu, H.; Guo, H. F.; Ouerfelli, O.; Larson, S.; Cheung, N. K.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • KEYNOTE-604: Pembrolizumab (pembro) or placebo plus etoposide and platinum (EP) as first-line therapy for extensive-stage (ES) small-cell lung cancer (SCLC)
    Meeting Abstract

    Rudin, C. M.; Awad, M. M.; Navarro, A.; Gottfried, M.; Peters, S.; Csoszi, T.; Cheema, P. K.; Rodriguez-Abreu, D.; Wollner, M.; Czyzewicz, G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Phase II study of TAK228 in patients with advanced non-small cell lung cancer (NSCLC) harboring NFE2L2 and KEAP1 mutations
    Meeting Abstract

    Paik, P. K.; Ahn, L. S. H.; Plodkowski, A. J.; Fan, P. D.; Rudin, C. M.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save